Participant eaten grapefruit or grapefruit solutions within 3 days prior to the 1st dose of study drug. then boost H3K27Ac at this area. Chromatin hyperacetylation could enhance the accessibility of your transcriptional regulatory sites and initiate MYC In Segment C, participants will acquire ABBV-744 and oral navitoclax. In Phase D, https://abbv-744-clinical-trial-p24578.blog4youth.com/32528845/abbv-744-cancer-treatment-clinical-trials-an-overview